PRRT2 and melanoma: Overall, our data demonstrate that PKC-θ is enriched in dysfunctional PD1+/CD8+ T cells derived from resistant melanoma patients and that, in dysfunctional PD1+/CD8+ T cells, PKC-θ forms a nuclear complex with ZEB1 that may potentially drive the CD8+ T-cell exhaustion phenotype.